| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Replimune Group Inc is a clinical-stage biotechnology company committed to applying its expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients through novel oncolytic immunotherapies. …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| FQ2 '27 | 10/28/267:00 AM | -$0.77 | -$0.54GAAP | +29.9% | +40% | $1.20M | $0 | -100% | — | |
| FQ1 '27 | 8/14/268:00 AM | -$0.76 | -$0.72GAAP | +5.3% | +24% | $7.53M | $0 | -100% | — | |
| FQ4 '26 | 6/29/268:00 AM | -$0.70 | -$0.76GAAP | -8.6% | +7% | $5.57M | $0 | -100% | — | |
| FQ3 '26 | 2/3/268:00 AM | -$0.83 | -$0.77GAAP | +7.2% | +3% | $3.20M | $0 | -100% | — | |
| FQ2 '26 | 11/6/258:00 AM | -$0.82 | -$0.90GAAP | -9.8% | -32% | $0.50M | $0 | -100% | — | |
| FQ1 '26 | 8/7/258:00 AM | -$0.82 | -$0.95GAAP | -15.9% | -22% | $3.16M | $0 | -100% | — | |
| FQ4 '25 | 5/22/257:00 AM | -$0.69 | -$0.82GAAP | -18.8% | 0% | — | $0 | — | — |
GAAP = diluted EPS as filed with the SEC.